Evaluation of Selective and Stepwise Excavation in Young Permanent Teeth With Deep Caries Lesions.
Launched by KAROLINSKA INSTITUTET · Apr 21, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to study two different methods for treating deep dental cavities in young permanent teeth, specifically in children and teenagers aged 8 to 19 years. The researchers want to compare selective removal of decayed tissue with stepwise removal to see which method works better in the long run. Participants will have their treatment followed up at one year and again at three years to assess how successful the treatment was in keeping the teeth healthy.
To be eligible for this trial, children must have fully erupted molars or premolars with significant decay that can be seen on dental X-rays. They should also be able to come back for follow-up visits for at least one year. However, children who are scheduled for tooth extraction or have severe issues with the tooth’s health will not be included. If your child qualifies and participates, they will receive treatment and be monitored for their recovery and dental health in the following years. This study aims to improve how we treat dental cavities in young patients, helping to keep their teeth strong and healthy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 8- 19 years (last December the year they turn 19 years) A fully erupted molar or pre-molar teeth with dental caries (class I or class II) extending to more than 2/3 of the dentine thickness (and on the bitewing radiograph showing a radiodense zone separating the pulp from the demineralized dentine).
- • Bitewing radiograph has been taken as part of the ordinary dental examination Available for recall at least for 1 year.
- Exclusion Criteria:
- • Extraction is planned of the tooth with deep caries in the future with expected spontaneous gap closure.
- If the carious tooth shows sign or symptoms of irreversible pulp pathology or loss of vitality including:
- • Presence of a sinus tract (fistula)
- • Tenderness to percussion
- • Buccal tenderness
- • Severe sensitivity
- • Evidence of pathology on a periapical radiograph (if radiograph is clinically justified and performed)
- • No written informed consent.
- • Medical condition requiring special considerations with regard of the dental management
- • Dental treatment cannot be performed adequate due to lack cooperation
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported